Earnings callsGufic Biosciences Limited
Every summarised call, newest first. Latest is Q1 FY27, held 17 Aug 2026.
- Q1 FY27Positive tone
Gufic Biosciences delivered strong Q1 growth driven by improved margins from its new Indore plant, progress on complex injectable capabilities, and a strategic shift in its international business model.